Source Control Review in Clinical Trials of Anti-infective Agents in Complicated Intra abdominal Infections

作者: J. S. Solomkin , R. L. Ristagno , A. F. Das , J. B. Cone , S. E. Wilson

DOI: 10.1093/CID/CIT128

关键词:

摘要: In clinical trials of complicated intra-abdominal infections, assessment adequacy the initial surgical approach to management infection is considerable importance in determining outcome. Antibiotic therapy would not be expected adequately treat if procedure was inadequate with respect source control. Inclusion such cases an efficacy analysis a particular therapeutic antibiotic may confound results. We analyzed control review process used double-blind antibiotics infections identified through systematic review. searched MEDLINE (PubMed) and ClinicalTrials.gov databases identify relevant articles reporting results from that process. Eight prospective, randomized, doubleblind, multicenter, 5 anti-infective agents provide recommendations for independent, adjudicated applicable future trials.

参考文章(10)
Ohmann C, Yang Q, Hau T, Wacha H, Prognostic modelling in peritonitis. Peritonitis Study Group of the Surgical Infection Society Europe. European Journal of Surgery. ,vol. 163, pp. 53- 60 ,(1997)
Joseph S Solomkin, Harald H Reinhart, E Patchen Dellinger, John M Bohnen, Ori D Rotstein, Stephen B Vogel, H Hank Simms, Carol S Hill, H Stephen Bjornson, Daniel C Haverstock, Holly O Coulter, Roger M Echols, Intra-Abdominal Infection Study Group, Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections Annals of Surgery. ,vol. 223, pp. 303- 315 ,(1996) , 10.1097/00000658-199603000-00012
Joseph S Solomkin, Albert E Yellin, Ori D Rotstein, Nicolas V Christou, E Patchen Dellinger, Jose M Tellado, Osvaldo Malafaia, Alvaro Fernandez, Kyuran A Choe, Alexandra Carides, Vilas Satishchandran, Hedy Teppler, Protocol 017 Study Group, None, Ertapenem Versus Piperacillin/Tazobactam in the Treatment of Complicated Intraabdominal Infections: Results of a Double-Blind, Randomized Comparative Phase III Trial Annals of Surgery. ,vol. 237, pp. 235- 245 ,(2003) , 10.1097/01.SLA.0000048551.32606.73
H. Wacha, T. Hau, R. Dittmer, C. Ohmann, Risk factors associated with intraabdominal infections: a prospective multicenter study Langenbeck's Archives of Surgery. ,vol. 384, pp. 24- 32 ,(1999) , 10.1007/S004230050169
Paul N. Suding, Russell P. Orrico, Steven B. Johnson, Samuel E. Wilson, Concordance of interrater assessments of surgical methods to achieve source control of intra-abdominal infections American Journal of Surgery. ,vol. 196, pp. 70- 73 ,(2008) , 10.1016/J.AMJSURG.2007.06.029
Joseph S. Solomkin, Samuel E. Wilson, Nicholas V. Christou, Ori D. Rotstein, E. Patchen Dellinger, Robert S. Bennion, Raphael Pak, Kenneth Tack, Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections. Annals of Surgery. ,vol. 233, pp. 79- 87 ,(2001) , 10.1097/00000658-200101000-00013
John E. Mazuski, Ellen J. Baron, Robert G. Sawyer, Avery B. Nathens, Joseph T. DiPiro, Timothy Buchman, E. Patchen Dellinger, John Jernigan, Sherwood Gorbach, Anthony W. Chow, John Bartlett, Joseph S. Solomkin, Guidelines for the Selection of Anti-infective Agents for Complicated Intra-abdominal Infections Clinical Infectious Diseases. ,vol. 37, pp. 997- 1005 ,(2003) , 10.1086/378702
Timothy Babinchak, Evelyn Ellis Grosse, Nathalie Dartois, Gilbert M Rose, Evan Loh, Tigecycline 301 and 306 Study Groups, None, The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra-Abdominal Infections: Analysis of Pooled Clinical Trial Data Clinical Infectious Diseases. ,vol. 41, ,(2005) , 10.1086/431676